IL27 and hepatocellular carcinoma: IL-27 strongly induced STAT1-dependent pathways and weakly induced STAT3-dependent pathways implicated in flaring up the viral infection and HCC progression in liver viral infection, suggesting the probable use of IL-27 as a safe treatment in viral hepatitis [40, 41].